A translational approach to novel medication development for protracted abstinence

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Alcohol dependence is a chronic, relapsing condition with high relapse rates.
• Current behavioral and pharmacological treatments for alcohol dependence have limited long-term efficacy.
• There is a critical need for improved strategies to prevent relapse in alcohol dependence.

Purpose of the Study:

• To review validated animal and human laboratory models for assessing relapse risk in alcohol dependence.
• To identify neurobiological treatment targets derived from these models.
• To propose a translational framework for accelerating medication development for alcohol dependence.

Main Methods:

• Review of existing literature on animal and human laboratory models of alcohol dependence relapse.
• Analysis of neurobiological targets identified through these models.
• Evaluation of translational approaches for drug development in alcohol dependence.
• Review of empirical findings from human laboratory studies.

Main Results:

• Validated animal and human laboratory models exist for assessing relapse risk.
• These models have identified key neurobiological targets for intervention.
• A translational approach using existing medications can refine research paradigms.
• Human laboratory models with predictive validity are crucial for evaluating drug efficacy.

Conclusions:

• Validated models and identified neurobiological targets offer promise for novel treatments.
• A translational framework can accelerate the development of effective medications for alcohol dependence.
• Careful selection of human laboratory models is essential for successful drug evaluation.